Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-14 | CVI Investments, Inc. | Evofem Biosciences, Inc. | 102,799 | 0.9% | EDGAR |
SC 13G/A | 2023-02-14 | CVI Investments, Inc. | Evofem Biosciences, Inc. | 7,033,373 | 5.5% | EDGAR |
SC 13G/A | 2022-08-10 | Cox Todd Stewart | Evofem Biosciences, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2022-07-19 | Cox Todd Stewart | Evofem Biosciences, Inc. | 3,919,866 | 9.3% | EDGAR |
SC 13G/A | 2022-02-14 | CVI Investments, Inc. | Evofem Biosciences, Inc. | 10,000,000 | 5.8% | EDGAR |
SC 13G/A | 2021-09-10 | MORGAN STANLEY | Evofem Biosciences, Inc. | 196,829 | 0.1% | EDGAR |
SC 13G/A | 2021-07-12 | BlackRock Inc. | Evofem Biosciences, Inc. | 3,395,720 | 2.3% | EDGAR |
SC 13G | 2021-06-04 | MORGAN STANLEY | Evofem Biosciences, Inc. | 7,631,470 | 5.1% | EDGAR |
SC 13G | 2021-05-28 | CVI Investments, Inc. | Evofem Biosciences, Inc. | 15,567,602 | 9.9% | EDGAR |
SC 13D/A | 2021-05-20 | Invesco Ltd. | Evofem Biosciences, Inc. | 591,960 | - | EDGAR |
SC 13D/A | 2021-04-27 | Invesco Ltd. | Evofem Biosciences, Inc. | 8,698,775 | 8.4% | EDGAR |
SC 13D/A | 2021-03-31 | Invesco Ltd. | Evofem Biosciences, Inc. | 9,849,545 | 9.9% | EDGAR |
SC 13G/A | 2021-02-12 | SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC/ DE | Evofem Biosciences, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2021-02-02 | BlackRock Inc. | Evofem Biosciences, Inc. | 5,213,684 | 6.4% | EDGAR |
SC 13G/A | 2020-06-23 | Link Fund Solutions Ltd | Evofem Biosciences, Inc. | 0 | 0.0% | EDGAR |
SC 13D/A | 2020-06-09 | Invesco Ltd. | Evofem Biosciences, Inc. | 13,226,532 | 16.8% | EDGAR |
SC 13G/A | 2020-06-09 | BlackRock Inc. | Evofem Biosciences, Inc. | 1,883,791 | 3.0% | EDGAR |
SC 13G | 2020-06-09 | ACACIA RESEARCH CORP | Evofem Biosciences, Inc. | 1,000 | 0.0% | EDGAR |
SC 13D/A | 2020-05-26 | PDL BIOPHARMA, INC. | Evofem Biosciences, Inc. | 3,333,334 | 6.3% | EDGAR |
SC 13G | 2020-03-09 | BlackRock Inc. | Evofem Biosciences, Inc. | 7,939,696 | 17.0% | EDGAR |